The melanoma differentiation associated gene mda-7 suppresses cancer cell growth
- PMID: 8799171
- PMCID: PMC38612
- DOI: 10.1073/pnas.93.17.9160
The melanoma differentiation associated gene mda-7 suppresses cancer cell growth
Abstract
Cancer is a disease characterized by defects in growth control, and tumor cells often display abnormal patterns of cellular differentiation. The combination of recombinant human fibroblast interferon and the antileukemic agent mezerein corrects these abnormalities in cultured human melanoma cells resulting in irreversible growth arrest and terminal differentiation. Subtraction hybridization identifies a melanoma differentiation associated gene (mda-7) with elevated expression in growth arrested and terminally differentiated human melanoma cells. Colony formation decreases when mda-7 is transfected into human tumor cells of diverse origin and with multiple genetic defects. In contrast, the effects of mda-7 on growth and colony formation in transient transfection assays with normal cells, including human mammary epithelial, human skin fibroblast, and rat embryo fibroblast, is quantitatively less than that found with cancer cells. Tumor cells expressing elevated mda-7 display suppression in monolayer growth and anchorage independence. Infection with a recombinant type 5 adenovirus expressing antisense mda-7 eliminates mda-7 suppression of the in vitro growth and transformed phenotype. The ability of mda-7 to suppress growth in cancer cells not expressing or containing defects in both the retinoblastoma (RB) and p53 genes indicates a lack of involvement of these critical tumor suppressor elements in mediating mda-7-induced growth inhibition. The lack of protein homology of mda-7 with previously described growth suppressing genes and the differential effect of this gene on normal versus cancer cells suggests that mda-7 may represent a new class of cancer growth suppressing genes with antitumor activity.
Similar articles
-
Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.Oncogene. 2001 Oct 25;20(48):7051-63. doi: 10.1038/sj.onc.1204897. Oncogene. 2001. PMID: 11704829
-
Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression.Oncogene. 1995 Dec 21;11(12):2477-86. Oncogene. 1995. PMID: 8545104
-
AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.J Cell Physiol. 2000 Oct;185(1):36-46. doi: 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V. J Cell Physiol. 2000. PMID: 10942517
-
mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S23-37. Cancer Biol Ther. 2003. PMID: 14508078 Review.
-
Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy.Adv Exp Med Biol. 2000;465:239-61. doi: 10.1007/0-306-46817-4_22. Adv Exp Med Biol. 2000. PMID: 10810631 Review. No abstract available.
Cited by
-
Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo.Tumour Biol. 2013 Aug;34(4):2419-26. doi: 10.1007/s13277-013-0792-1. Epub 2013 Apr 23. Tumour Biol. 2013. PMID: 23609032
-
Enhanced apoptosis-inducing function of MDA-7/IL-24 RGD mutant via the increased adhesion to tumor cells.J Interferon Cytokine Res. 2012 Feb;32(2):66-73. doi: 10.1089/jir.2011.0040. Epub 2012 Jan 16. J Interferon Cytokine Res. 2012. PMID: 22248086 Free PMC article.
-
RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes.Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12684-9. doi: 10.1073/pnas.220431297. Proc Natl Acad Sci U S A. 2000. PMID: 11058161 Free PMC article.
-
Crystal Structure of the Labile Complex of IL-24 with the Extracellular Domains of IL-22R1 and IL-20R2.J Immunol. 2018 Oct 1;201(7):2082-2093. doi: 10.4049/jimmunol.1800726. Epub 2018 Aug 15. J Immunol. 2018. PMID: 30111632 Free PMC article.
-
Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.PLoS One. 2007 Dec 12;2(12):e1300. doi: 10.1371/journal.pone.0001300. PLoS One. 2007. PMID: 18074024 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous